Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 1 Jul 2011 |
| Genmab Announces Zalutumumab Update | 24 Jun 2011 |
| Grant of Warrants to Board Members, Management and Employees in Genmab | 22 Jun 2011 |
| Report Pursuant to Section 28a of the Danish Securities Trading Act | 22 Jun 2011 |
| Genmab to Attend Two June Investor Conferences | 25 May 2011 |